The Effect of Cervical Stellate Ganglion Block Using Botulinum Toxin Type A in Intractable Cancer-related Pain: Case Report
- Author:
Donggyun SOHN
1
;
Geun Young PARK
;
Sun IM
;
Sang Hoon JEON
;
Yongmin CHOI
Author Information
1. Department of Rehabilitation Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
- Publication Type:Case Report
- Keywords:
Cancer pain;
Botulinum toxin;
Cervical stellate ganglionic block
- MeSH:
Botulinum Toxins;
Botulinum Toxins, Type A;
Humans;
Methods;
Morphine;
Neuralgia;
Stellate Ganglion
- From:
Clinical Pain
2018;17(2):107-110
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: For patients who do not relieve with pharmacological intervention, interventional treatment including neurolytic blocks may have a specific role in palliative cancer management.METHOD: We performed cervical stellate ganglion block for the second time with Botulinum toxin type A mixed with 4 ml of normal saline, total 75 IU of Botulinum toxin type A, minimal effective dosage was measured to minimize the possible side effects.RESULTS: About 3 days later, the patient reported that her continuous pain intensity had decreased from 8/10 to 4/10 on the visual analogue scale score. The frequency of the pain attack that required additional morphine injections was also decreased. As a result, her maximum morphine requirement dose per day was significantly reduced.CONCLUSION: In this case, cervical stellate ganglion block with Botulinum toxin hadlonger lasting effect in the continuous pain intensity and resulted in less frequent pain attack. Botulinum toxin can be a possibleintervention material in intractable neuropathic pain related to cancer.
